Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
8hon MSN
Adds Kenvue comment. Kenvue (NYSE:KVUE) needs to focus on fixing its skin, health and beauty segments, Jeff Smith, founder ...
Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster ...
Jeff Smith says pharma giant’s returns from recent efforts are ‘not adequate’ in speech at 13D activist investor conference ...
Kenvue has a formidable lineup of well-known consumer health brands, such as Aveeno, Tylenol, Band-Aid, Zirtec, Listerine, ...
Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its ...
By Svea Herbst-Bayliss (Reuters) -Hedge fund Starboard Value called consumer products company Kenvue a bargain and said its ...
In Asia, focus remains on Beijing’s efforts to boost growth in its struggling economy via stimulus. In the latest move, ...
The S&P 500 fell 0.2% on Monday. The Dow tumbled 0.8%, ending a three-day winning streak for the blue-chip index. After ...
JPMorgan analyst Andrea Teixeira keeps an Overweight rating on Kenvue (KVUE) after the Wall Street Journal reported Starboard Value has taken a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback